Original language | English |
---|---|
Pages (from-to) | 355-363 |
Journal | Multiple Sclerosis and Related Disorders |
Volume | 3 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2014 |
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS)
B.O. Khatri, J. Pelletier, L. Kappos, H.P. Hartung, G. Comi, F. Barkhof, P. von Rosenstiel, X. Meng, A. Grinspan, R. Hashmonay, J.A. Cohen
Research output: Contribution to journal › Article › Academic › peer-review
12
Citations
(Scopus)